Zdrowie i gospodarka · 30/10/2003

FDA Releases Guidance on West Nile Virus Serological Reagents

The Food and Drug Administration (FDA) has released a guidance document outlining the requirements for serological reagents used to diagnose West Nile Virus, which is now in effect as a special control for class II devices. The document is open to public comment and aims to ensure compliance with FDA regulations.